Aim: In present survey, we attempted to inquire the plausible linkage of rs1327474 A/G and HCV chronic infection or the clearance of the virus. Background: IFN-γ signaling pathway is an important trigger for activating antiviral immune responses and production of wide variety of molecules with anti-microbial profiles including type 1 cytokines. Any defect or variation in IFNG signaling pathway may result in susceptibility or progression to diverse diseases such as inflammatory and virus associated disorders. Rs1327474 A/G also known as-611 A/G is an important variation which is located in promoter region of Interferon Gamma Receptor-I (IFNGR1) and may have potent risk for HCV susceptibility. Methods: For this purpose, 154 HCV patients and 200 controls were enrolled in the study, and genomic DNA was isolated from PBMCS and IFNGR1-611 polymorphism was genotyped by polymerase chain reaction-fragments length polymorphism (PCRRFLP) method. Results: While, AA, AG and GG genotypes frequency included 37. 8%, 53. 7%, 8. 5% in healthy controls, 41. 6%, 46. 1%, 12. 3% were found in chronic HCV patients. Interestingly, allelic percentage was similar in both separated groups within 64. 7%, 35. 3% and 65. 3%, 34. 7% were obtained for T and G allele in control and case group respectively. Conclusion: In spite of our exception for the possible role of this variation in an important promoter region of IFGR1 gene, rs1327474 A/G was not associated with HCV chronic infection among an Iranian studied group. Comprehensively,-611A/G cannot be considered as a risk biomarker for susceptibility to chronic HCV disease.